drug class of tirzepatide TIRZEPATIDE.pptx GLP-1 receptor agonists for type

Today, they are FDA-approved not only for managing blood sugar and reducing body weight, but also for treating obstructive sleep apnea and lowering the risk of serious cardiovascular events like heart attacks and strokes

Unlike brand-name GLP-1s, these products are not FDA-approved, so safety, purity, and effectiveness may vary

It helps to reduce the signs of aging, such as fine lines and sagging skin, while also promoting a radiant complexion

Diabetes Obes Metab 12 , 815824 (2010)

Your prescriber will advise when to stop Mounjaro and when to start Wegovy tablets, based on your current dose, side effects, treatment history, and weight loss progress

Clinical research involving thousands of participants has established that semaglutide demonstrates an overall favorable risk/benefit profile with semaglutide producing mostly mild-to-moderate and transient side effects, primarily gastrointestinal in nature